X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs WOCKHARDT - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

WOCKHARDT 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE WOCKHARDT CADILA HEALTHCARE/
WOCKHARDT
 
P/E (TTM) x 13.2 -14.0 - View Chart
P/BV x 2.6 1.0 262.4% View Chart
Dividend Yield % 1.6 0.0 40,475.7%  

Financials

 CADILA HEALTHCARE   WOCKHARDT
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
WOCKHARDT
Mar-18
CADILA HEALTHCARE/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs5581,012 55.1%   
Low Rs362532 68.0%   
Sales per share (Unadj.) Rs116.3355.9 32.7%  
Earnings per share (Unadj.) Rs17.9-60.3 -29.6%  
Cash flow per share (Unadj.) Rs23.1-46.8 -49.5%  
Dividends per share (Unadj.) Rs3.500.01 35,000.0%  
Dividend yield (eoy) %0.80 58,752.0%  
Book value per share (Unadj.) Rs85.4257.8 33.1%  
Shares outstanding (eoy) m1,023.74110.63 925.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.02.2 182.3%   
Avg P/E ratio x25.7-12.8 -201.0%  
P/CF ratio (eoy) x19.9-16.5 -120.4%  
Price / Book Value ratio x5.43.0 179.8%  
Dividend payout %19.60 -118,073.3%   
Avg Mkt Cap Rs m470,66485,379 551.3%   
No. of employees `00011.86.3 189.0%   
Total wages/salary Rs m18,5459,371 197.9%   
Avg. sales/employee Rs Th10,072.76,295.0 160.0%   
Avg. wages/employee Rs Th1,569.11,498.3 104.7%   
Avg. net profit/employee Rs Th1,547.7-1,066.3 -145.1%   
INCOME DATA
Net Sales Rs m119,04939,369 302.4%  
Other income Rs m1,1321,202 94.2%   
Total revenues Rs m120,18140,571 296.2%   
Gross profit Rs m28,47518 155,601.1%  
Depreciation Rs m5,3881,495 360.3%   
Interest Rs m9112,555 35.7%   
Profit before tax Rs m23,308-2,830 -823.7%   
Minority Interest Rs m6280-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3,582 0.0%   
Tax Rs m5,644257 2,196.1%   
Profit after tax Rs m18,292-6,669 -274.3%  
Gross profit margin %23.90 51,456.6%  
Effective tax rate %24.2-9.1 -266.6%   
Net profit margin %15.4-16.9 -90.7%  
BALANCE SHEET DATA
Current assets Rs m82,00533,796 242.6%   
Current liabilities Rs m60,72026,917 225.6%   
Net working cap to sales %17.917.5 102.3%  
Current ratio x1.41.3 107.6%  
Inventory Days Days7379 92.2%  
Debtors Days Days9889 110.2%  
Net fixed assets Rs m83,70339,664 211.0%   
Share capital Rs m1,024553 185.1%   
"Free" reserves Rs m86,42127,968 309.0%   
Net worth Rs m87,44528,522 306.6%   
Long term debt Rs m25,55121,731 117.6%   
Total assets Rs m180,65381,620 221.3%  
Interest coverage x26.6-0.1 -24,726.0%   
Debt to equity ratio x0.30.8 38.3%  
Sales to assets ratio x0.70.5 136.6%   
Return on assets %10.6-5.0 -210.9%  
Return on equity %20.9-23.4 -89.5%  
Return on capital %22.0-7.7 -286.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42,6839,807 435.2%   
Fx outflow Rs m11,2421,789 628.5%   
Net fx Rs m31,4418,019 392.1%   
CASH FLOW
From Operations Rs m9,193684 1,343.2%  
From Investments Rs m-9,7376,302 -154.5%  
From Financial Activity Rs m515-7,695 -6.7%  
Net Cashflow Rs m-29-664 4.4%  

Share Holding

Indian Promoters % 74.8 74.5 100.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 2.3 360.9%  
FIIs % 5.9 7.7 76.6%  
ADR/GDR % 0.0 0.1 -  
Free float % 11.0 15.4 71.4%  
Shareholders   44,069 67,757 65.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  ALEMBIC LTD  ALEMBIC PHARMA  ELDER PHARMA  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Falling Stocks, Tumbling Rupee and Weakening Economy(Podcast)

Another week of slowdown in the markets over fears of a looming slowdown in the domestic and global economy continue.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (3QFY19); Net Profit Down 80.6% (Quarterly Result Update)

Jan 29, 2019 | Updated on Jan 29, 2019

For the quarter ended December 2018, WOCKHARDT LTD. has posted a net profit of Rs 769 m (down 80.6% YoY). Sales on the other hand came in at Rs 10 bn (up 4.0% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

More Views on News

Most Popular

This 60-Year Old Smallcap Company Could Be Our Next Recommendation(The 5 Minute Wrapup)

Aug 12, 2019

My experience at the recent AGM of this smallcap company which has financials of any FMCG major.

Interest Rates Are Low. Buy Solid Dividend Stocks Instead(The 5 Minute Wrapup)

Aug 13, 2019

The dividends paid by these stocks are helpful when interest rates are falling.

My Top 3 Dividend Stocks to Buy Now(Profit Hunter)

Aug 19, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Smallcaps that Will Outperform in the Market Rebound(Profit Hunter)

Aug 12, 2019

Only These Smallcaps Will Give Historic Returns in the Future.

One Stock You Could Consider Buying Now and Holding Forever(The 5 Minute Wrapup)

Aug 22, 2019

If there is one company that I could recommend that is making the most of the tech disruption, this would be it.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Aug 23, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS